📈 Stocks
Molecular Glue Deals Surpass $1 Billion, Cementing Cancer Drug Breakthrough
(47 days ago)
Billion-dollar molecular glue deals reshape the cancer drug landscape, driving biotech valuations and pharma licensing activity to new highs.